SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · Real-Time Price · USD
3.410
-0.010 (-0.29%)
At close: Sep 11, 2026, 4:00 PM EDT
3.500
+0.090 (2.64%)
After-hours: Sep 11, 2026, 7:30 PM EDT
SAB Biotherapeutics Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Revenue Revenue Growth | - | - | - | 0.11 | 0.11 | 0.38 | 1.32 | 1.51 | 2.78 | 2.6 | 2.24 | 4.09 | 6.42 | 12.68 | 23.9 | 32.8 | 43.89 | 55.75 | 60.88 | 75.57 |
Revenue Growth | - | - | - | -92.42% | -95.87% | -85.48% | -40.94% | -63.06% | -56.68% | -79.48% | -90.63% | -87.52% | -85.38% | -77.25% | -60.73% | -56.60% | -43.99% | -15.73% | 10.21% | - |
Gross Profit Gross Profit Growth | -48.27 | -39.09 | -33.35 | -30.46 | -29.32 | -28.69 | -28.23 | -25.38 | -20.31 | -17.52 | -14.28 | -15.26 | -16.27 | -14.97 | -12.53 | -7.15 | -3.77 | -1.97 | 3.69 | 1.13 |
Operating Income Operating Income Growth | -71.82 | -58.18 | -48.95 | -43.19 | -41.82 | -42.29 | -42.91 | -51.78 | -45.79 | -42.06 | -38.08 | -27.06 | -29.55 | -29.61 | -28.92 | -28.4 | -24.58 | -20.91 | -13.39 | 2.53 |
Net Income Net Income Growth | -21.79 | -9.41 | 4.26 | -21.37 | -37.06 | -34.28 | -34.11 | -45.57 | -40.32 | -39.87 | -42.19 | -27.21 | -29.19 | -27.08 | -18.74 | -22.42 | -19.4 | -17.57 | -17.14 | 6.93 |
Earnings Per Share EPS Growth | -1.56 | -2.05 | -0.79 | -4.49 | -3.99 | -3.70 | -3.68 | -5.28 | -5.29 | -6.07 | -7.64 | -5.49 | -6.18 | -5.97 | -4.31 | -5.60 | -5.42 | -5.60 | -6.30 | 1.47 |
EPS Growth | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Cash & Investments Cash & Investments Growth | 102.63 | 107.39 | 96.59 | 110.88 | 5.71 | 12.85 | 20.76 | 30.4 | 37.33 | 44.06 | 56.57 | 2.43 | 7.77 | 13.06 | 15.05 | 8.33 | 16.62 | 22.41 | 33.21 | 10.75 |
Total Debt Total Debt Growth | 5.13 | 6.17 | 5.95 | 6.19 | 6.42 | 6.78 | 4.67 | 4.52 | 5.34 | 5.45 | 5.91 | 4.65 | 4.9 | 5.46 | 5.93 | 5.8 | 6.09 | 6.41 | 8.52 | 6.82 |
Net Cash (Debt) Net Cash Growth | 97.5 | 101.22 | 90.64 | 104.69 | -0.71 | 6.07 | 16.09 | 25.88 | 31.98 | 38.61 | 50.66 | -2.23 | 2.87 | 7.6 | 9.12 | 2.53 | 10.53 | 16 | 24.69 | 3.93 |
Net Cash Growth | - | 1568.24% | 463.28% | 304.53% | - | -84.28% | -68.23% | - | 1014.26% | 408.01% | 455.59% | - | -72.73% | -52.49% | -63.07% | -35.66% | 217.39% | 256.69% | 450.61% | - |
Net Cash Per Share Net Cash Per Share Growth | 2.03 | 3.33 | 1.48 | 10.87 | -0.08 | 0.65 | 1.74 | 3.00 | 4.19 | 5.87 | 9.17 | -0.45 | 0.61 | 1.68 | 2.09 | 0.63 | 2.93 | 5.06 | 9.03 | 2.13 |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -53.94 | -51.25 | -44.78 | -37.53 | -30.77 | -31.34 | -34.29 | -38.21 | -37.08 | -34.26 | -25.12 | -13.23 | -15.98 | -15.53 | -23.46 | -26.78 | -15.07 | -17 | 1.99 | 11.4 |
Capital Expenditures CapEx Growth | -3.5 | -1.92 | -0.93 | -0.06 | -0.16 | -0.21 | -0.34 | -0.35 | -0.33 | -0.3 | -0.2 | -0.25 | -0.24 | -0.83 | -2.17 | -4.41 | -7.56 | -10.41 | -10.94 | -13.94 |
Free Cash Flow Free Cash Flow Growth | -57.44 | -53.17 | -45.71 | -37.59 | -30.93 | -31.55 | -34.63 | -38.56 | -37.42 | -34.57 | -25.32 | -13.47 | -16.22 | -16.36 | -25.63 | -31.19 | -22.63 | -27.42 | -8.96 | -2.55 |
Free Cash Flow Growth | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Gross Margin | - | - | - | - | - | - | - | - | - | - | - | - | -253.56% | -118.02% | -52.44% | -21.79% | -8.60% | -3.54% | 6.07% | 1.49% |
Operating Margin | - | - | - | -37656.99% | -36462.89% | -11193.25% | -3244.87% | -3422.67% | -1647.04% | -1616.31% | -1700.56% | -660.87% | -460.42% | -233.50% | -120.97% | -86.59% | -56.01% | -37.51% | -22.00% | 3.35% |
Pretax Margin | - | - | - | 16338.36% | -32306.67% | -9071.77% | -2579.03% | -3012.27% | -1450.33% | -1531.84% | -1884.50% | -663.91% | -454.40% | -214.06% | -78.29% | -68.34% | -44.21% | -31.35% | -28.16% | 3.77% |
Profit Margin | - | - | - | -18629.82% | -32306.67% | -9071.77% | -2579.03% | -3012.28% | -1450.33% | -1531.84% | -1884.50% | -664.53% | -454.80% | -213.53% | -78.40% | -68.34% | -44.20% | -31.51% | -28.16% | 9.17% |
FCF Margin | - | - | - | -32770.92% | -26966.38% | -8349.52% | -2618.65% | -2548.80% | -1345.90% | -1328.30% | -1130.71% | -329.07% | -252.74% | -128.98% | -107.20% | -95.10% | -51.55% | -49.17% | -14.71% | -3.37% |
| Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
PE Ratio | - | - | 41.78 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 21.51 |
PS Ratio | - | - | - | 772.10 | 142.17 | 33.44 | 26.48 | 16.47 | 10.29 | 16.09 | 28.33 | 8.05 | 6.52 | 1.75 | 1.24 | 0.92 | 1.42 | 2.90 | 5.58 | 1.97 |